货号:GS40344
Isatuximab (brand name Sarclisa®) is a humanized monoclonal IgG1κ antibody approved for the treatment of relapsed or refractory multiple myeloma (RRMM). It functions as a targeted immunotherapy against CD38, a cell surface antigen highly expressed on myeloma cells. Isatuximab exerts its anti-myeloma effects through multiple, complementary mechanisms.
武汉迈思生物科技有限公司
联系商家时请提及chemicalbook,有助于交易顺利完成!
迈思生物